Completes Major Steps Towards Profitability with Best Revenue and Adjusted EBITDA in Over Three Years TORONTO, May 15, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three months ended March 31, 2024.

VANCOUVER, BC, May 15, 2024 /CNW/ - May 16, 2025 – Sydney, Australia HighlightsContinued strong lithium mineralization over wide intervals from infill drilling at CV5.122.5 m at 1.42% Li2O, including 35.8 m at 2.15% Li2O (CV24-405).71.4 m at 1.57% Li2O, including 14.2 m at 3.15% Li2O (CV24-435).68.7 m at 1.56% Li2O and 22.5 m at 1.04% Li2O (CV24-414).74.9 m at 1.28% Li2O, including 28.1 m at 2.28% Li2O (CV24-423A).53.0 m at 1.22% Li2O, including 25.0 m at 1.65% Li2O (CV24-450).The focus of the 2024 winter drilling at CV5 was to support an upgrade in mineral resource confidence, from the inferred category ...

VANCOUVER, BC, May 14, 2024 /CNW/ - Eastern Platinum Limited (TSX: ELR) (JSE: EPS) ("Eastplats" or the "Company") is pleased to report that it has filed its condensed interim consolidated financial statements for the three months ended March 31, 2024 and the corresponding management's discussion and analysis ("MD&A"). Below is a summary of the Company's financial results for the first quarter of 2024 ("Q1 2024") in comparison to the restated period in 2023 ("Restated Q1 2023") (all amounts in USD unless specified)...

(All dollar figures are in US dollars unless otherwise indicated) TORONTO, May 17, 2024 /CNW/ - New Gold Inc. ("New Gold" or the "Company") (TSX: NGD) (NYSE American: NGD) is pleased to announce the closing of its "bought deal" equity financing of 100,395,000 common shares, including 13,095,000 common shares issued upon the full exercise of the underwriters' over-allotment option. At a price of $1.72 per common share, the Company raised aggregate gross proceeds of $172,679,400 pursuant to the offering. The offering, announced on May 13, 2024, was conducted by a syndicate of underwriters led by CIBC Capital Markets and that ...